MARSHALL WACE, LLP - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$226,501
-67.2%
5,900
-84.9%
0.00%
-100.0%
Q4 2022$691,416
+873.8%
38,953
+368.4%
0.00%
Q4 2021$71,000
-88.8%
8,316
-88.6%
0.00%
-100.0%
Q3 2021$633,000
+249.7%
72,822
+324.2%
0.00%
+200.0%
Q2 2021$181,000
-46.8%
17,167
-19.0%
0.00%
-50.0%
Q1 2021$340,000
+34.9%
21,194
+288.5%
0.00%
+100.0%
Q4 2020$252,000
-83.7%
5,455
-91.4%
0.00%
-90.9%
Q2 2020$1,546,000
+798.8%
63,511
+475.5%
0.01%
+450.0%
Q1 2020$172,00011,0360.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2020
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,007,000$25,620,0003.77%
Deep Track Capital, LP 4,775,000$40,683,0002.87%
Octagon Capital Advisors LP 572,862$4,881,0000.95%
Eventide Asset Management 4,950,000$42,174,0000.54%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,197,0000.44%
FRAZIER MANAGEMENT LLC 585,759$4,991,0000.38%
MANGROVE PARTNERS IM, LLC 688,000$5,862,0000.35%
BCK CAPITAL MANAGEMENT LP 54,293$463,0000.31%
EcoR1 Capital, LLC 1,140,819$9,720,0000.31%
MANGROVE PARTNERS IM, LLC 570,400$4,860,0000.29%
View complete list of IMMUNOVANT INC shareholders